GlassScriptPhysician profile
Martin C Hightower
NPI 1972582617
$2,145.73
in general payments reported to CMS, 2019-2025
15 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.49 · 2021: $703 · 2022: $164 · 2023: $490 · 2024: $483 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $497.11 | 2021-2024 | Provenge |
| Myriad Genetic Laboratories, INC. | $420.24 | 2021-2024 | Prolaris |
| Bioprotect Medical, INC. | $239.80 | 2024-2025 | Bioprotect Balloon Implant System |
| Bayer Healthcare Pharmaceuticals INC. | $209.11 | 2019-2024 | |
| Boston Scientific Corporation | $185.62 | 2021-2024 | Spaceoar Vue System - 10ml |
| Astellas Pharma Global Development | $137.52 | 2024 | Xtandi |
| Progenics Pharmaceuticals, INC. | $136.92 | 2022-2025 | |
| Palette Life Sciences, INC. | $110.37 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $47.40 | 2024-2025 | Orgovyx |
| Astrazeneca Pharmaceuticals LP | $38.89 | 2024-2025 | Lynparza |
| Astellas Pharma US INC | $27.77 | 2024 | Xtandi |
| Siemens Medical Solutions USA, INC. | $25.32 | 2024 | Somatom Go.Top |
| Telix Pharmaceuticals | $24.99 | 2023 | Illuccix |
| Teleflex LLC | $23.93 | 2025 | Urolift |
| Tolmar Pharmaceuticals, INC. | $20.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Hightower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.